Carl Zeiss rises after GS upgrade on China stabilization

Carl Zeiss Meditec AG

11/03/2025 11:52

** Shares in Carl Zeiss Meditec AG AFXG.DE rise around 6% after Goldman Sachs upgraded the German optical systems maker to "buy" from "neutral"

** GS analyst Richard Felton cites positive developments in the Chinese market, which shows signs of stabilization

** Felton projects an increase in H2 revenue in thanks to the approval in China of Visumax 800, a laser device used by surgeons

** Including today's rise the stock has gained 36.75 % YTD; it lost 4% on Monday after J.P.Morgan placed it on negative catalyst watch

​

 (Reporting by Simon Ferdinand Eibach)

 ((Simonferdinand.eibach@thomsonreuters.com))